Black–Scholes model

Kelso Technologies Inc. Financial Results for the Year Ended December 31, 2023

Retrieved on: 
Tuesday, March 26, 2024

The Company had income tax payable of $10,024 at December 31, 2023 compared to $30,626 at December 31, 2022.

Key Points: 
  • The Company had income tax payable of $10,024 at December 31, 2023 compared to $30,626 at December 31, 2022.
  • Total assets of the Company were $9,703,271 as at December 31, 2023 compared to $12,147,143 as at December 31, 2022.
  • Net assets of the Company were $8,720,248 as at December 31, 2023 compared to $10,781,672 as at December 31, 2022.
  • The Company had no interest-bearing long-term liabilities or debt as at December 31, 2023 or December 31, 2022.

Goldmoney Inc. Announces Closing of Schiff Gold Sale and Cancellation of Securities

Retrieved on: 
Saturday, December 2, 2023

Pursuant to the terms of a securities exchange agreement dated December 1, 2023, Goldmoney received 212,600 common shares of Goldmoney (the “Goldmoney Shares”) and 280,000 common share purchase warrants of Goldmoney (the “Goldmoney Warrants” and, together with the Goldmoney Shares, the “Goldmoney Securities”) in consideration for all of Goldmoney’s membership interests in SGL.

Key Points: 
  • Pursuant to the terms of a securities exchange agreement dated December 1, 2023, Goldmoney received 212,600 common shares of Goldmoney (the “Goldmoney Shares”) and 280,000 common share purchase warrants of Goldmoney (the “Goldmoney Warrants” and, together with the Goldmoney Shares, the “Goldmoney Securities”) in consideration for all of Goldmoney’s membership interests in SGL.
  • The Goldmoney Shares have a deemed value of approximately CAD $1,798,596 (equivalent to CAD$8.46 per share for 212,600 Goldmoney Shares), and the Goldmoney Warrants have a deemed value of approximately $147,657 based on a Black-Scholes valuation.
  • Upon closing of the Transaction, the Goldmoney Shares were cancelled by the Company (the “Cancellation”).
  • Under applicable securities regulations, Mr. Peter Schiff is a related party of SGL (being an affiliated entity of Goldmoney) and a control person of the Purchaser.

Bioretec Ltd's Board of Directors has decided on a new option program 2023-1

Retrieved on: 
Friday, October 20, 2023

A maximum total of 1,000,000 option rights will be issued, and they will entitle their owners to subscribe for a maximum total of 1,000,000 new shares in the company.

Key Points: 
  • A maximum total of 1,000,000 option rights will be issued, and they will entitle their owners to subscribe for a maximum total of 1,000,000 new shares in the company.
  • The option rights will be issued free of charge.
  • The theoretical market value of one option right is approximately EUR 1.283 and the theoretical market value of all option rights combined is approximately EUR 1,283,357.
  • Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants.

Bioretec Ltd's Board of Directors has decided on a new option program 2023-1

Retrieved on: 
Friday, October 20, 2023

A maximum total of 1,000,000 option rights will be issued, and they will entitle their owners to subscribe for a maximum total of 1,000,000 new shares in the company.

Key Points: 
  • A maximum total of 1,000,000 option rights will be issued, and they will entitle their owners to subscribe for a maximum total of 1,000,000 new shares in the company.
  • The option rights will be issued free of charge.
  • The theoretical market value of one option right is approximately EUR 1.283 and the theoretical market value of all option rights combined is approximately EUR 1,283,357.
  • Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants.

Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023

Retrieved on: 
Monday, September 25, 2023

Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023

Key Points: 
  • Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023
    The issuer is solely responsible for the content of this announcement.
  • Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023
    London, United Kingdom | September 07, 2023 12:54 PM Eastern Daylight Time
    Bumper , a decentralised finance (DeFi) protocol, today launched its crypto options killer .
  • Until now, the methodology for calculating the price for hedging risk relied on the fifty-year-old Black-Scholes model, which has fuelled the $13 trillion options market.
  • For more information on Bumper, including their early user rewards and incentives for rival DeFi options protocol users visit bumper.fi .

Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023

Retrieved on: 
Saturday, September 16, 2023

Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023

Key Points: 
  • Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023
    The issuer is solely responsible for the content of this announcement.
  • Bumper’s $20m bid to undercut Deribit Crypto Options goes live on September 7, 2023
    London, United Kingdom | September 07, 2023 12:54 PM Eastern Daylight Time
    Bumper , a decentralised finance (DeFi) protocol, today launched its crypto options killer .
  • Until now, the methodology for calculating the price for hedging risk relied on the fifty-year-old Black-Scholes model, which has fuelled the $13 trillion options market.
  • For more information on Bumper, including their early user rewards and incentives for rival DeFi options protocol users visit bumper.fi .

Timber Pharmaceuticals to be Acquired by LEO Pharma

Retrieved on: 
Monday, August 21, 2023

As part of the transaction, LEO Pharma has agreed to provide Timber with a bridge loan of up to $3.0 million, subject to certain conditions.

Key Points: 
  • As part of the transaction, LEO Pharma has agreed to provide Timber with a bridge loan of up to $3.0 million, subject to certain conditions.
  • The payments of the CVRs are subject to certain deductions relating to the repayment of 50% of the bridge loan provided by LEO Pharma to Timber in connection with the merger.
  • LEO Pharma is a leader in global dermatology with a mission that matches our own - a relentless pursuit to help patients suffering from skin diseases.
  • Covington & Burling LLP is serving as legal counsel to LEO Pharma.

Flow Capital announces 5-year investment performance

Retrieved on: 
Monday, June 5, 2023

Warrant values are calculated using Black-Scholes pricing and are not increased unless there is an external equity financing event.

Key Points: 
  • Warrant values are calculated using Black-Scholes pricing and are not increased unless there is an external equity financing event.
  • The combined entity was subsequently renamed Flow Capital Corp.
  • “Recent market dynamics have created an environment in which the demand for Flow Capital’s funding has grown dramatically.
  • Deal flow has accelerated in recent months, and it is our expectation that much more capital will be deployed into more great growth companies at a faster rate,” said Mr. Baluta.

OverActive Media Announces Mailing of Management Information Circular, Option/RSU Exchange and Stock Option Grants

Retrieved on: 
Friday, June 2, 2023

Under the option/RSU exchange, holders of outstanding stock options (other than directors of the Company) will be offered the opportunity to exchange their stock options for newly issued RSUs.

Key Points: 
  • Under the option/RSU exchange, holders of outstanding stock options (other than directors of the Company) will be offered the opportunity to exchange their stock options for newly issued RSUs.
  • Any RSUs issued pursuant to the option/RSU exchange will be issued in accordance with the terms of the Company's 2022 Omnibus Equity Incentive Plan.
  • Further details regarding the option/RSU exchange may be found in the Company's management information circular, a copy of which is available under the Company's SEDAR profile at www.sedar.com .
  • OverActive does not intend, and does not assume any obligation, to update the forward-looking statements except as otherwise required by applicable law.

Bumper’s Breakthrough DeFi Protocol Set to Reshape Options Pricing

Retrieved on: 
Thursday, June 1, 2023

Marking a seismic shift in the digital asset landscape, DeFi platform Bumper today unveiled the findings of their comprehensive simulation, exhibiting new pricing efficiencies over traditional options desks ahead of the protocol launch in August 2023.

Key Points: 
  • Marking a seismic shift in the digital asset landscape, DeFi platform Bumper today unveiled the findings of their comprehensive simulation, exhibiting new pricing efficiencies over traditional options desks ahead of the protocol launch in August 2023.
  • Key highlights from the simulation report:
    On average, Bumper Takers paid 9.3% cheaper premia than buyers of traditional put options.
  • During the 2022 bear market, Bumper’s simulation showed a yield improvement of 46.2% for Makers compared to options pricing, without resorting to token incentives.
  • The report underscores the anticipated outcomes of Bumper's dynamic pricing, based on forward volatility rather than the usual implied volatility.